Biological Therapy and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
Status:
Terminated
Trial end date:
2009-01-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Biological therapies such as poly-ICLC use different ways to stimulate the immune
system and stop tumor cells from growing. Radiation therapy uses high-energy x-rays to damage
tumor cells. Combining biological therapy with radiation therapy may kill more tumor cells.
PURPOSE: Phase II trial to study the effectiveness of combining poly-ICLC with radiation
therapy in treating patients who have newly diagnosed glioblastoma multiforme.
Phase:
Phase 2
Details
Lead Sponsor:
North American Brain Tumor Consortium Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins